Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

News

September 28, 2016
Fish & Richardson Principals Juanita Brooks, Michael Headley Rank Among Daily Journal’s “Top IP Attorneys for 2016” List
September 28, 2016
Fish's John Dragseth Quoted in Law360 Article "PTAB Appeals Face Tough Road After Latest Fed. Circ. Ruling"
Fish Litigation Blog
September 27, 2016
Amgen’s Humira Biosimilar Becomes the Fourth FDA Approved Biosimilar
Authors: Holly Chamberlain, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
September 23, 2016
Fish's Eric Schulman and John Hayden Quoted in Law360 Article "Fish & Richardson Lands Ex-Uber IP Head, Google Patent Pro"
September 23, 2016
Fish's Eric Schulman and John Hayden Quoted in The Recorder Article "Fish & Richardson Hires Uber IP Director"
Fish Litigation Blog
September 21, 2016
FDA to Hold Public Meeting on Biosimilar User Fees
Authors: Rachel Bandli, Tasha M. Francis, Ph.D.
September 21, 2016
Fish's Ryan McCarthy Quoted in Law360 Article "How Recent Case Law Can Be Used To Fight Alice Challenges"
September 21, 2016
Fish & Richardson Named Among Most Feared Firms in Litigation in BTI Litigation Outlook 2017
Fish Patent Blog
September 21, 2016
PTAB Bar Association Officially Launched
Authors: Dorothy P. Whelan, W. Karl Renner, Thomas Rozylowicz
Fish Litigation Blog
September 20, 2016
Amgen Argues “Entire Balance of BPCIA” in Jeopardy unless Federal Circuit Overturns Discovery Ruling
Authors: Holly Chamberlain, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
Fish Litigation Blog
September 19, 2016
The Dance Continues: Apotex Petitions the Supreme Court for Review
Authors: Will Orlady, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
load more news

Stay current with Fish Sign up for our Newsletter